Robert Kallmeier

Director, Programme Management at Quell Therapeutics - Hammersmith and Fulham, ENG, UK

Robert Kallmeier's Colleagues at Quell Therapeutics
Jamie H.

Laboratory Assistant

Contact Jamie H.

Anthony Sowerbutts

upon - Thames, England, United Kingdom - Research Associate in R&D

Contact Anthony Sowerbutts

Deppo Juneja

Scientific Project Manager

Contact Deppo Juneja

Chrysi Christodoulidou

Research Associate - Product Research

Contact Chrysi Christodoulidou

Yogesh Kamra

Immune monitoring Scientist

Contact Yogesh Kamra

View All Robert Kallmeier's Colleagues
Robert Kallmeier's Contact Details
HQ
N/A
Location
Company
Quell Therapeutics
Robert Kallmeier's Company Details
Quell Therapeutics logo, Quell Therapeutics contact details

Quell Therapeutics

Hammersmith and Fulham, ENG, UK • 100 - 249 Employees
BioTech/Drugs

An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.Our company is growing and we are exciting about the future! Our vision is to become a world leader in new cell therapy and the people are at the heart of what we do. We treat our people with respect, working collaboratively across the business, taking ownership and accountability for the outcomes and results we delivery. Most of all we work with integrity to innovate and bring the best version of ourselves to the job every day.

N/A
Details about Quell Therapeutics
Frequently Asked Questions about Robert Kallmeier
Robert Kallmeier currently works for Quell Therapeutics.
Robert Kallmeier's role at Quell Therapeutics is Director, Programme Management.
Robert Kallmeier's email address is ***@quell-tx.com. To view Robert Kallmeier's full email address, please signup to ConnectPlex.
Robert Kallmeier works in the Research industry.
Robert Kallmeier's colleagues at Quell Therapeutics are Jamie H., Anthony Sowerbutts, Deppo Juneja, Marc Martinez-Llordella, Marta Sunyer, Chrysi Christodoulidou, Yogesh Kamra and others.
Robert Kallmeier's phone number is N/A
See more information about Robert Kallmeier